Abstract:Combination of tissue-engineered bone scaffolds with cell-adhesive, osteoconductive, or osteoinductive biomolecules is a critical strategy to improve their properties that significantly influence cellular behaviors, such as adhesion, proliferation, and differentiation, which is beneficial for critical-sized bone defects repairing. However, the traditional surface modification techniques, such as physical adsorption, coating, and plasma treatment, et al, have great limitations for immobilization of bioactive molecules due to undesirable controlled delivery performance or overly complex multistep procedures. In this study, we functionalized the chitosan/hydroxyapatite (CS/HA) biomimetic composite scaffold for controlled delivery of BMP2-derived peptide (P24) by the chemical grafting modification technique: firstly, P24 was conjugated with a thiolated chitosan, chitosan-4-thiobutylamidine (CS-TBA); secondly, the resultant CS-P24 was then combined with HA to prepare CS-P24/HA scaffolds. The effect of CS-P24/HA scaffolds on bone regeneration was evaluated, along with the underlying biological mechanisms responsible in vitro and in vivo. In vitro, the controlled and sustained release of bioactive P24 could last up to 90 days, furthermore, the release profiles of CS-5%P24/HA and CS-10%P24/HA were linear and could be fitted according to zero-order kinetic model (R2=0.9929; R2=0.9757); P24 on the scaffold significantly promoted cell adhesion, proliferation, osteodifferentiation, and mineralization with synergistic effects. Bone marrow stromal cells (BMSCs) revealed spindle-shaped surface morphology, indicating the CS-P24/HA scaffolds supported cell adhesion and possessed a high proliferation rate that varied according to the P24 concentration levels. Furthermore, mRNA levels for OCN, Runx2, and collagen I were significantly up-regulated on CS-P24/HA scaffolds compared with cells grown on CS/HA scaffolds in vitro (p < 0.05). Similarly, the BMSCs exhibited a higher ALP expression and calcium deposition level on CS-P24/HA scaffolds compared with CS/HA scaffolds (p < 0.05). In vivo, osteoinductive studies revealed a significantly higher ectopic osteogenesis level of CS-10%P24/HA scaffolds in rat dorsal muscle pockets compared with that of CS/HA scaffolds. Finally, CS-P24/HA scaffolds showed superior performance in the reconstruction of rat calvarial bone defects. This novel CS-P24/HA scaffold is deemed a strong potential candidate for the repair of bone defects in human bone tissue engineering.

Enhancement of bone formation by recombinant human bone morphogenetic protein-2/chitosan bone biomaterials

Studies on Recombinant Human Bone Morphogenetic Protein 2 Loaded Nano-Hydroxyapatite/Silk Fibroin Scaffolds

In Vitro Experimental Study on Chitosan As Carrier for Sustained Release of Recombinant Human Bone Morphogenetic Protein-2

Sustained delivery of BMP-2 enhanced osteoblastic differentiation of BMSCs based on surface hydroxyapatite nanostructure in chitosan-HAp scaffold

Effect of Recombinant Human Bone Morphogenetic Protein Delivered by Chitosan Microspheres on Ectopic Osteogenesis in Rats.

Calcium sulfate hemihydrate/mineralized collagen for bone tissue engineering: In vitro release and in vivo bone regeneration studies

[In Vitro Osteogenesis of the Compound of Chitosan and Recombinant Human Bone Morphogenetic Protein 2].

Degradable release and osteogenesis of recombinant human bone morphogenetic protein 2 system with water-soluble chitosan

Enhanced Healing of Rat Calvarial Defects with Sulfated Chitosan-Coated Calcium-Deficient Hydroxyapatite/bone Morphogenetic Protein 2 Scaffolds.

Efficient Delivery of Recombinant Human Bone Morphogenetic Protein (Rhbmp-2) with Dextran Sulfate-Chitosan Microspheres

Zero-order controlled release of BMP2-derived peptide P24 from the chitosan scaffold by chemical grafting modification technique for promotion of osteogenesis in vitro and enhancement of bone repair in vivo

BMP-2 Plasmid DNA-loaded Chitosan Films – A New Strategy for Bone Engineering

Localization and Promotion of Recombinant Human Bone Morphogenetic Protein-2 Bioactivity on Extracellular Matrix Mimetic Chondroitin Sulfate-Functionalized Calcium Phosphate Cement Scaffolds.

MBG Scaffolds Containing Chitosan Microspheres for Binary Delivery of IL-8 and BMP-2 for Bone Regeneration.

Hollow hydroxyapatite microspheres/chitosan composite as a sustained delivery vehicle for rhBMP-2 in the treatment of bone defects

Enhanced Osteogenesis of Bone Morphology Protein-2 in 2-N,6-o-sulfated Chitosan Immobilized PLGA Scaffolds.

Enhancement of Bone Formation by Bone Morphogenetic Protein-2 Released from Poly (L-Lactic-co-glycolic Acid) Microsphere

Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo.

Sustained Delivery of BMP-2-Related Peptide from the True Bone Ceramics/Hollow Mesoporous Silica Nanoparticles Scaffold for Bone Tissue Regeneration

Enhanced Loading and Controlled Release of Rhbmp-2 in Thin Mineralized Collagen Coatings with the Aid of Chitosan Nanospheres and Its Biological Evaluations.

Accelerated Bone Regenerative Efficiency by Regulating Sequential Release of BMP-2 and VEGF and Synergism with Sulfated Chitosan.